Share

    


Home / Search Results

Search Results

You searched for:

    Displaying results 1 - 20 of 84
  • 1
  • 2
  • 3
  • 4
  • 5
  • »
June is Cancer Immunotherapy Month, and ACCC is highlighting the important work that it and its partners are doing to increase patient access to these novel therapies.
ACCCBuzz spoke with Erika Siegrist at Luminis Health Research Institute to learn more about how technology has helped expand patient access to cancer clinical trials.
This May, ACCC is recognizing Bladder Cancer Awareness Month with a message highlighting the importance of awareness, patient education, and support.
ACCCBuzz spoke with Dr. Gabriela Hobbs, MD, at Massachusetts General Hospital Cancer Center to learn how to best manage patients' care for those with myelofibrosis.
ACCCBuzz spoke with Luis E. Raez, MD, FACP, FCCP, to learn more about the importance of closing the gap in access to biomarker testing and strategies to improve equity and inclusion in precision medicine.
ACCCBuzz spoke with Julie Huynh-Lu, PA-C—physician assistant in the Department of Leukemia at the University of Texas MD Anderson Cancer Center—to learn more about enhancing the care for patients with myelofibrosis by assessing and addressing their psychosocial and financial health.
With the variety of models and titles that have emerged under precision medicine stewardship, learn how one cancer program is breaking down the this complex landscape into streamlined workflows to improve efficiency and better support growing test volumes.
ACCC highlights 2022 workforce trends and how healthcare organizations can improve employee moral with proven leadership.
The first post in ACCC's "Subspeciality Immuno-Oncology Insights" series—the APP perspective and real-world strategies for tackling current challenges in the delivery of immunotherapies for cancer.
ACCC shares how a precision medicine steward—a dedicated navigator focused specifically on biopsy samples and biomarker testing processes and results—can make a daunting biomarker testing process incredibly efficient for cancer programs and practices everywhere.
On November 10, 2022, ACCC President Dr. David R. Penberthy, MBA, held his third in a series of four Tech Talks, where invited subject matter experts and ACCC members discussed remote patient monitoring (RPM) in cancer care.
ACCCBuzz spoke with Dr. Jessica Unzaga at Baptist Health’s Miami Cancer Institute, to help consider the use of triplet vs. quadruplet regimens in the treatment of multiple myeloma.
Learn how a thriving revenue cycle management process ensures well-timed revenue, steady collection, and healthy financial viability for a healthcare organization, while focusing on providing high-quality care to patients.
November 13 to 19 is dedicated to National Nurse Practitioner Week, and the Association of Community Cancer Centers (ACCC) is taking this opportunity to recognize its nurse practitioner (NP) members—highlighting the work NPs do to improve access to care, the patient and clinician experience, and patient outcomes.
Dr. Barbara Schmidtman highlights key findings from the 2022 ACCC Mini Z burnout survey, comparing results from the pre-pandemic 2019 to now.
Introduced in 2021, the Cancer Patient Equity Act seeks to provide coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program, and more.
In recognition of American Pharmacists Month, ACCCBuzz spoke to Dr. Sarah Hudson-DiSalle at The James Cancer Hospital to learn more about her role on the cancer care team.
Healthcare—especially oncology—is rife with competing demands that make it particularly challenging to engage oncology staff in innovation. #ACCCNOC keynote speaker Julie Holmes shares her principles for innovating in healthcare through “little big bangs” (or micro-innovations).
The ACCC 39th National Oncology Conference opened with two pre-conferences, covering financial advocacy in oncology and the future of cancer care. Learn what care delivery may look like in 2040 and how ACCC is supporting cancer programs and practices through its Financial Advocacy Network.
With the treatment of chronic lymphocytic leukemia (CLL) shifting substantially in the last five years, learn how ACCC is supporting oncology professionals in integrating oral oncolytics in CLL practice.
    Displaying results 1 - 20 of 84
  • 1
  • 2
  • 3
  • 4
  • 5
  • »